Quantbot Technologies’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Buy
5,582
+3,727
+201% +$110K 0.01% 1272
2026
Q1
$51.4K Sell
1,855
-751
-29% -$19.3K ﹤0.01% 1413
2025
Q4
$56.5K Buy
+2,606
New +$51.4K ﹤0.01% 1501
2023
Q3
Sell
-13,900
Closed -$140K 1899
2023
Q2
$140K Buy
13,900
+13,880
+69,400% +$124K 0.01% 1088
2023
Q1
$148 Sell
20
-32,446
-100% -$267K ﹤0.01% 1479
2022
Q4
$259K Buy
+32,466
New +$181K 0.02% 799
2022
Q1
Sell
-1,600
Closed -$16K 1991
2021
Q4
$16K Buy
+1,600
New +$13.3K ﹤0.01% 1253

Other funds holding ROIV

Quantbot Technologies's ROIV Position: Q2 2026 in Review

Quantbot Technologies increased its Roivant Sciences (ROIV) stake by 201% in Q2 2026, buying an estimated $110K and bringing the position to 5,582 shares worth $198K. The position accounts for 0.01% of the portfolio, ranked #1272.

Quantbot Technologies first reported a position in ROIV in Q4 2021 and has held it in 7 quarters since. The position peaked at $259K in Q4 2022. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Quantbot Technologies held 5,582 shares of Roivant Sciences worth $198K as of Q2 2026.
  • Quantbot Technologies bought 3,727 Roivant Sciences shares in Q2 2026, an estimated $110K.
  • Roivant Sciences made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1272 holding.
  • Quantbot Technologies first reported a position in Roivant Sciences in Q4 2021 and has held it in 7 quarters since.
  • Quantbot Technologies's Roivant Sciences position peaked at $259K in Q4 2022.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.